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Abstract
Background: Direct in vivo investigation of human metabolism is complicated by the distinct metabolic functions
of various sub-cellular organelles. Diverse micro-environments in different organelles may lead to distinct functions
of the same protein and the use of different enzymes for the same metabolic reaction. To better understand the
complexity in the human metabolism, a compartmentalized human metabolic network with integrated sub-cellular
location information is required.
Results: We extended the previously reconstructed Edinburgh Human Metabolic Network (EHMN) [Ma, et al.
Molecular Systems Biology, 3:135, 2007] by integrating the sub-cellular location information for the reactions,
adding transport reactions and refining the protein-reaction relationships based on the location information. Firstly,
protein location information was obtained from Gene Ontology and complemented by a Swiss-Prot location
keywords search. Then all the reactions in EHMN were assigned to a location based on the protein-reaction
relationships to get a preliminary compartmentalized network. We investigated the localized sub-networks in each
pathway to identify gaps and isolated reactions by connectivity analysis and refined the location information based
on information from literature. As a result, location information for hundreds of reactions was revised and
hundreds of incorrect protein-reaction relationships were corrected. Over 1400 transport reactions were added to
link the location specific metabolic network. To validate the network, we have done pathway analysis to examine
the capability of the network to synthesize or degrade certain key metabolites. Compared with a previously
published human metabolic network (Human Recon 1), our network contains over 1000 more reactions assigned
to clear cellular compartments.
Conclusions: By combining protein location information, network connectivity analysis and manual literature
search, we have reconstructed a more complete compartmentalized human metabolic network. The whole
network is available at http://www.ehmn.bioinformatics.ed.ac.uk and free for academic use.
Background
Direct in vivo investigation of human metabolism is
complicated by the distinct metabolic functions of dif-
ferent sub-cellular locations. For example, lysosomes are
organelles containing digestive enzymes that break down
polymeric macromolecules into their smaller building
blocks. The lysosome membrane enables an acidic inter-
nal environment (pH less than 5 rather than around 7
in the cytosol) to maximize the enzyme activities [1].
Due to localization of metabolic enzymes, many meta-
bolic processes involve coordinated interactions between
different organelles, and one metabolic step may be
dependent upon the successful completion of the pre-
vious step. For example, the decomposition of very long
chain fatty acids (VLCFAs) is a process shared by per-
oxisomes and mitochondria. Likewise, the final steps in
the synthesis of plasmologens occur in the endoplasmic
reticulum, but the process depends on precursors which
are synthesized in peroxisomes [2]. At the regulation
level, the efficacy of many cellular processes is depen-
dent on proper regulation of proteins trafficking to and
from their site(s) of action. The endoplasmic reticulum
(ER) and Golgi apparatus (GA) are known as the main
organelles for protein targeting or protein sorting which
transport proteins to the appropriate locations inside a
cell or outside of it [3]. Therefore it is quite usual that
an enzyme synthesized in ER may be active only in
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another sub-cellular location. In addition, diverse micro-
environments in different organelles may lead to distinct
functions of the same enzyme. For example, acid cera-
midase (EC 3.5.1.23; AC) is the lipid hydrolase responsi-
ble for the degradation of ceramide into sphingosine
and free fatty acids within lysosomes. However, at
higher pH in the cytosol AC can also synthesize cera-
mide from sphingosine and free fatty acids [4]. Reduced
lysosomal AC activity causes Farber disease, which is a
member of a group of diseases called lysosomal storage
diseases (LSDs) which results from defects in lysosomal
enzyme function [5]. Therefore, determining the loca-
tion of enzymes and reactions is important for the
investigation of the mechanism of a metabolic process
and its related diseases. Currently there are two high
quality literature based human metabolic networks avail-
able, the Edinburgh Human Metabolic Network
(EHMN) reconstructed by our group [6] and the
Human Recon 1 reconstructed by Palsson’s group [7].
Human Recon 1 contains eight sub-cellular locations
while EHMN did not include location information [6].
Localization of reactions in Human Recon 1 was deter-
mined from “protein localization data, sequence target-
ing signals, and indirect physiological evidence”. If these
data were unavailable, reactions were assigned to cyto-
plasm (cytosol in the data downloaded from BiGG) [7].
As mentioned in our previous paper, EHMN is a more
complete network with 1028 more reactions and 1202
more metabolites [6]. Therefore, it is valuable to EHMN
to include the information on sub-cellular location dis-
tribution of proteins and reactions. In this work, we
chose 8 locations for enzyme proteins mainly based on
information from GO (Gene Ontology) [8]. The localiza-
tion of reactions was initially determined by protein
locations and then the gaps and isolated reactions in the
preliminary compartmentalized network were examined
and revised based on information from literature. By
integrating the protein location information and the
reaction (metabolite) location information, we also cor-
rected hundreds of wrong protein-reaction relationships
in EHMN. Furthermore, over 1400 transport reactions
were added in order to obtain a connected compart-
mentalized network. The metabolic pathways for the
synthesis and degradation of dozens of metabolites were
investigated to validate the reconstructed network.
Results and discussion
1. Localization based on protein location
1.1 Protein location information
There are 15904 human proteins associated with one
or more GO (Gene Ontology) terms in the “cellular
component” part. They were classified into the eight
selected high level locations including: cytosol, nucleus,
Endoplasmic Reticulum (ER), Golgi apparatus (GA),
peroxisomes, lysosomes, mitochondria and extracellular
(See Methods and Figure 1). Proteins associated with
“cell part” or some other locations not within the
above eight locations were assigned to “uncertain”.
From Swiss-Prot keywords we obtained location infor-
mation for 4908 human proteins and among them 154
proteins have no clear location information from GO.
In the case that a protein has different locations in the
two resources, we choose to assign the protein to all
the locations. Altogether we obtained location informa-
tion for 16058 human proteins and 2026 of them are
in EHMN (summarized in Table 1). The high number
of proteins allocated to “uncertain” reflects the fact
that our knowledge on protein location distribution is
still very limited.
1.2 Sub-cellular localization of reactions
The reactions in EHMN were assigned to different loca-
tions based on the protein-reaction relationships and
the obtained protein location information. There are
also 448 non-enzyme catalyzed (or enzyme unknown)
reactions and 143 reactions with unknown protein loca-
tion information. They were assigned to “uncertain”
location by default. In this way all the reactions in
EHMN were assigned to the 9 locations and their distri-
bution is shown in Table 2.
It should be noted that one reaction may be catalyzed
by different enzymatic proteins and these proteins can
be in different locations. For example, R00342 ((S)-
Malate + NAD+ = Oxaloacetate + NADH + H+) can be
catalyzed by two proteins: MDH2 and MDH1, which
function in cytosol and mitochondria respectively. Fig-
ure 2 shows a summary of 4 different types of protein-
reaction-location relationships: One reaction may be
catalyzed by one (type a) or multiple proteins. When a
reaction is catalyzed by multiple proteins, these proteins
can be active in the same (type b) or in different loca-
tions. For example, R00256 (L-Glutamine + H2O = L-
Glutamate + NH3) is catalyzed by two proteins: GLS1
and GLS2. They both function in mitochondria but in
different organs (kidney and liver) [9,10]. R00342 men-
tioned above belongs to type c where two proteins are
in totally different locations. There are also cases in
which some proteins for one reaction may have com-
mon locations but some of them may also have their
unique locations (type d). For example, R05987 (UDP-
N-acetyl-D-glucosamine + (GlcNAc)4 (Man)3 (Asn)1 =
UDP + (GlcNAc)5 (Man)3 (Asn)1) is catalyzed by pro-
teins MGAT4A, MGAT4B and MGAT4C. They all exist
in GA but MGAT4A can also be secreted to extracellu-
lar space. However, the expression locations of these
enzymes in tissues are somehow different although they
have the common sub-cellular locations in cells.
MGAT4A and MGAT4C are expressed in almost totally
different organs. Whereas MGAT4B is widely expressed
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in many human tissues and highly over-expressed in
pancreatic cancer [11].
We paid special attention to type c in the four types.
Proteins catalyzing the same reaction in different loca-
tions are called “complementary proteins” in the study.
We identified 16 such complementary protein groups
(See additional file 1: Complementary groups and deleted
protein-reaction relationships in revision of type c reac-
tion). The two most common cases are: (a) the proteins
are in the cytosol and mitochondria respectively (as for
R00342 mentioned above); (b) the proteins are in peroxi-
somes and mitochondria respectively. Most of the protein
groups in case b are involved in lipid metabolism and
often catalyze a large class of reactions. As reported in lit-
erature, peroxisomes are the main places for the oxida-
tion of VLCFAs [2]. Therefore the protein location
information may be used to identify the correct reactions
catalyzed and thus improve the annotation of the pro-
tein-reaction relationships in EHMN. For example,
RE3139 (CoA + 3-oxo-all-cis-6,9,12,15,18,21-tetracosa-
hexaenoyl-CoA = acetyl-CoA + docosa-4,7,10,13,16,19-
all-cis-hexaenoyl-CoA) is a step in beta-oxidation of
Omega-3 fatty acid, which is a family of long chain and
very long chain unsaturated fatty acids and their oxida-
tion was known to take place in peroxisomes [12].
RE3139 is associated with four proteins (ACAA1,
ACAA2, HADHB and HADHA) in EHMN. However,
only ACAA1 is in peroxisomes and the other three are
mitochondria proteins. Therefore, the relationships
between RE3139 and the three mitochondrial proteins in
EHMN are wrong and should be corrected. Using this
method, we have removed 43 incorrect protein-reaction
relationships (See additional file 1: Complementary
groups and deleted protein-reaction relationships in revi-
sion of type c reaction).
2. Location revision based on pathway connectivity
analysis
According to the location of the reactions, we obtained
the reaction location distribution for all the pathways
Cellular
component
GO:0005575
Extracellular
GO:0005576
Cell part
GO:0044464
Cytoplasm
GO:0005737
Nucleus
GO:0005634
Cytosol
GO:0005829
Endoplasmic
reticulum
GO:0005783
Golgi
apparatus
GO:0005794
Peroxisomes
GO:0005777
Lysosomes
GO:0005764
Mitochondria
GO:0005739
Figure 1 The Gene Ontology terms used for protein locations. The eight selected top locations are circled. Proteins are matched to GO
terms and then backtracked to the eight selected locations through the hierarchical structure. “Cytosol” here includes the proteins on plasma
membrane.
Table 1 Protein distribution in different locations
GO location Number of
proteins
Proteins in
EHMN
GO:0005576 Extracellular 1969 145
GO:0044464 uncertain 12057 1606
GO:0005634 Nucleus 4668 391
GO:0005829 Cytosol 3782 380
GO:0005783 Endoplasmic
reticulum
848 236
GO:0005794 Golgi apparatus 671 173
GO:0005777 Peroxisomes 99 51
GO:0005764 Lysosomes 178 41
GO:0005739 Mitochondria 911 324
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in EHMN (See additional file 2: The reaction location
distribution in the pathways in EHMN). We found that
there are many poorly-studied pathways in which the
number of reactions in any one specific location
(excluding “uncertain”) is less than one quarter of the
total number of reactions in the pathway. This rather
patchy feature of the localized network indicates that
the location information from GO and SwissProt is
still quite limited and more information is needed to
improve the network for functional analysis. As the
first step, we tried to improve the network connectivity
by identifying the gaps or isolated reactions in the
localized network by network structure analysis.
From additional file 2 we can also see that there are
many cases in which only one isolated reaction in a
pathway exists in one location. Even when there are sev-
eral reactions in a pathway in the same location, they
may be separated by a reaction in another location
(defined as a gap) as shown in Figure 3. We need to
address these issues to improve the quality of the com-
partmentalized network.
2.1 Gap filling
As depicted in Figure 3, a gap is a reaction which is in a
different location with its two neighbour reactions in a
pathway. Details about the methods for gap identifica-
tion can be found in the Methods section. Altogether
Table 2 The distribution of reactions in different locations
location Number of reactions
original after revision of type c reaction after gap filling after IRLR revision after literature based revision
E 224 224 281 262 234
U 2481 2479 2163 2165 1929
N 218 218 265 252 226
C 650 650 775 726 892
ER 627 627 706 681 649
GA 228 228 255 248 241
X 378 360 386 376 291
L 123 123 134 116 108
M 793 779 877 866 740
reaction
(385)
protein 1 protein 2
SCLsc SCLsc
reaction
(753)
protein 1 protein 2
SCLs1 SCLsc SCLs2
reaction
(1085)
protein 1
reaction
(143)
protein 1 protein 2
SCLs2SCLs1
(a) (b)
(c) (d)
Figure 2 The different types of protein-reaction-location relationships. There are four types of protein-reaction-location relationships: (a)
one reaction is related to one protein; (b) one reaction is related to two or more proteins which are all in the same locations; (c) one reaction is
related to two or more proteins which are in completely different locations; (d) one reaction is related to two or more proteins which have
common locations, but some of them also have their unique location annotation. SCLsc stands for the common locations. The number of
reactions in each type is shown in the parentheses.
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we found 510 gaps from 360 reactions in the 69 path-
ways ("isolated” pathway was excluded). Interestingly, a
major part of the gap reactions (316 of 360) are in
“uncertain”. We directly assigned these reactions to the
corresponding location to fill the gaps. This gap filling
method is similar to previous approaches to identify the
gaps in a reconstructed metabolic network for searching
the missing genes/enzymes in pathways [13-15]. Now
we applied this connectivity-based gap filling method to
the localized network, thus complementing the patchy
location data obtained solely from protein location
information.
For the 49 gaps whose gap reactions are not in
“uncertain”, we used the information from the literature
to decide whether we should assign the gap reaction to
the corresponding location or not. Only those with posi-
tive evidences in the literature to support the existence
of a gap reaction in the missing location were filled.
Due to the limited research on reaction location, we
only found 8 gaps with positive evidence in the litera-
ture. For example, R03617 (Galactosylceramide + H2O =
beta-D-Galactose + N-Acylsphingosine) was identified as
a gap in extracellular whereas Dolcetta et al [16]
reported that the corresponding protein GALC actually
catalyzed the reaction in the extracellular space. For the
other 7 reactions, we found some new proteins that can
catalyze the reaction in the missing locations. For exam-
ple, one of the gaps in the di-unsaturated fatty acid
beta-oxidation pathway in peroxisomes can be filled by
adding reaction RE1516 (FAD + linoleoyl-CoA =
FADH2 + trans,cis,cis-2,9,12-octadecatrienoyl-CoA). In
EHMN, this reaction is catalyzed only by protein
ACADL which is active in mitochondria. However, Bode
and Couee [17] reported that two peroxisomal proteins:
ACOX1 and ACOX3 have the same catalytic activity as
ACADL. Therefore, RE1516 is catalyzed by ACOX1 and
ACOX3 in peroxisomes. In this case, we updated
EHMN by adding the protein-reaction relationships to
the database. Altogether we added 14 protein-reaction
relationships from literature and 469 gaps were filled,
including 461 gaps from reactions with “uncertain”
location and 8 gaps from reactions with other clear loca-
tions. The distribution of the reactions in each location
after gap filling is shown in Table 2.
2.2 Isolated reactions
Gap filling may join some isolated reactions in a loca-
tion together. However, even after gap filling, there are
still some isolated reactions as not all reactions can be
linked by a gap reaction. As for the gap definition, iso-
lated reactions are also location-specific. One reaction
may be isolated in two different locations. It can also be
an isolated reaction in one location but not isolated in
another location. More precisely it should be called an
isolated reaction-location relationship (IRLR). Altogether
we obtained 177 IRLRs by identifying the one-node con-
nected components in the location-specific pathway
graph and investigating them carefully in the literature.
We found that some of them are wrong because of (1)
incorrect reaction location annotation; (2) incorrect pro-
tein-reaction relationship in EHMN. In the first case,
the existence of a protein in a location does not mean
that the catalyzed reaction occurs in that location
because the protein may be not active. For example,
R03631 (ATP + Phytanate + CoA = AMP + Pyropho-
sphate + Phytanoyl-CoA) in the phytanic acid peroxiso-
mal oxidation pathway is catalyzed by protein SLC27A2
which exists in both peroxisomes and endoplasmic reti-
culum [18]. However, many researches [19-21] reported
that the oxidation of phytanic acid takes place in peroxi-
somes but not in endoplasmic reticulum. The activity of
SLC27A2 in endoplasmic reticulum may be involved in
the bile acid biosynthesis pathway to catalyze R04580
(ATP + 3alpha,7alpha,12alpha-Trihydroxy-5beta-choles-
tanoate + CoA = AMP + Pyrophosphate + 3alpha,
7alpha,12alpha-Trihydroxy-5beta-cholestanoyl-CoA)
(Figure 4) [22]. An example of the second case is
R04586 (GM2 + H2O = GM3 + N-Acetyl-D-galactosa-
mine), a GalNAc transformation reaction. In EHMN the
corresponding protein for this reaction is MGEA5.
However, the description of the function of MGEA5 in
Swiss-Prot is “it Cleaves GlcNAc but not GalNAc from
glycopeptides”. Therefore the annotation for MGEA5 in
Component IIComponent I
Mitochondria Mitochondria
M1
M2 M3 M4 M5 M6 M7
R1
R2 R3 R4 R5
uncertain
R6
Figure 3 An example of Gap filling based on pathway connectivity analysis. The two connected components in Mitochondria can be
linked by reaction R6 which is not in Mitochondria. Then R6 is a gap reaction and the gap could be filled by assign R6 to Mitochondria.
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EHMN was wrong and should be corrected. Altogether
7 protein-reaction relationships were deleted in this way.
For some isolated reactions, we found positive evi-
dence in the literature. For example, the L-Pipecolic
acid oxidation reaction R02204 (L-Pipecolate + Oxygen
= 2,3,4,5-Tetrahydropyridine-2-carboxylate + H2O2)
should occur in human peroxisomes. Its deficiency in
this location will cause a disease belonging to a group of
disorders called peroxisome biogenesis disorders (PBDs)
[23]. Even though it is the only reaction in Lysine meta-
bolism which occurs in peroxisomes, its location should
not be changed, especially considering that oxygen is a
reactant in this reaction. There are 19 such cases in our
network. It is very likely that these reactions may be
linked with other parts of the network through transport
reactions.
We did not find any related literature for more than
80% of the IRLRs. In this case, we decided to keep an
IRLR if the corresponding protein exists only in that
location and it does not catalyze other reactions. As dis-
cussed above, if the protein exists in several locations, it
may be inactive in the isolated location. Alternatively, if
a protein catalyzes several reactions, it may imply that
the protein may prefer to catalyze the other reaction(s)
rather than the isolated one. For example, reaction
R05989 (2 UDP-D-galactose + (GlcNAc)4 (LFuc)1
(Man)3 (Asn)1 = 2 UDP + (Gal)2 (GlcNAc)4 (LFuc)1
(Man)3 (Asn)1) in the N-Glycan biosynthesis pathway is
an isolated reaction in the cytosol. Protein B4GALT1 is
the protein related to this reaction in the cytosol but
this protein also functions in extracellular and GA
where it is connected with other reactions. In addition,
B4GALT1 is responsible for the synthesis of complex-
type N-linked oligosaccharides in many glycoproteins.
Therefore, even if B4GALT1 has activity in the cytosol,
its function may not be for reaction R05989 but
for some other reactions. Accordingly, the location
annotation of R05989 in the cytosol was deleted. How-
ever, further experimental studies would be needed to
validate such predictions. In all the 177 isolated reac-
tion-location relationships, 153 of them were revised,
including 9 revised because of incorrect protein-reaction
relationships and 144 without any related literature cita-
tions. The distribution of reactions in each location is
shown in Table 2.
3. Literature-based revision
The objective of gap filling and IRLR revision is to make
the compartmentalized network more amenable for
further network analysis and functional analysis. How-
ever, even after such structure-based revision, there are
still many pathways in which the number of reactions in
any one specific location (excluding “uncertain”) is less
than one third of the total number of reactions in the
pathway. To further improve the usability of the net-
work, we manually examined the location distribution of
all the pathways in EHMN, with a focus on pathway
level, to check the literature for location information
about a biological process including a series of reactions.
Although in total such information is still limited, we
did find evidences in textbooks or in the literature for a
number of pathways. In addition to the well known
mitochondrial occurrence of the TCA cycle pathway,
many studies are focused on the location of fatty acid
beta-oxidation pathways. Three main criteria were used
to decide the location of the beta-oxidation reaction.
Firstly, it was reported that very long chain (greater
than C-22) fatty acids underwent initial oxidation in
peroxisomes which ceases at octanyl CoA and was then
followed by mitochondrial oxidation [24]. Thus, the
length of fatty acid chain can be considered as a rule to
distinguish between beta-oxidation in mitochondria and
in peroxisomes. Secondly, oxidation reactions coupled
with ATP should occur in mitochondria while those
Figure 4 Isolated reaction-location relationship revision. Protein SLC27A2 is in both peroxisomes (X) and endoplasmic reticulum (ER) and it
can catalyze two reactions: R03631 and R04580. R03631 is the only reaction in endoplasmic reticulum in the Phytanic acid peroxisomal oxidation
pathway while there are other reactions connected with R04580 in endoplasmic reticulum in the Bile acid biosynthesis pathway. This strongly
suggests that SLC27A2 may only catalyze R03631 in peroxisome but not in endoplasmic reticulum.
Hao et al. BMC Bioinformatics 2010, 11:393
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coupled with H2O2 should be in peroxisomes [2]. The
third criterion is the knowledge on the location of some
specific metabolites. It has been reported that stearic
acid and palmitic acid are oxidized firstly in peroxi-
somes to octanyl CoA and then oxidized in mitochon-
dria. The unsaturated fatty acids (except very long chain
acids) can be oxidized in both peroxisomes and mito-
chondria [2]. According to the above criteria, the loca-
tions of 103 reactions in the beta-oxidation pathways
were revised. Due to the revised reaction location, the
incorrect protein-reaction relationships were also cor-
rected. For example, the location of R03856 (Lauroyl-
CoA + NADP+ = 2-trans-Dodecenoyl-CoA + NADPH +
H+) was revised from both peroxisomes and mitochon-
dria to peroxisomes only because it is a step in the
degradation of palmitic acid in peroxisomes before ceas-
ing at octanyl CoA. In EHMN, R03856 is linked with
two proteins: MECR in mitochondria and PECR in per-
oxisomes. The MECR-R03856 relationship can therefore
be deleted because the reaction only occurs in peroxi-
somes. In this way, a total of 129 protein-reaction rela-
tionships were deleted in the beta-oxidation pathways.
We also revised the location information for 337 reac-
tions in other pathways (e.g. Pentose phosphate path-
way, Valine, leucine and isoleucine degradation
pathway) based on evidences from textbooks or the lit-
erature and more than 120 incorrect protein-reaction
relationships were deleted (See additional file 3: Result
of literature-based revision). The reaction distribution in
each location is shown in Table 2.
The limited knowledge on sub-cellular location informa-
tion from databases was remedied to some extent by the
revisions described above. The Valine, leucine and isoleu-
cine degradation pathway is shown in Figure 5 as an
example to illustrate how the quality of the localized net-
work was improved. Firstly, in the step of revision of type
c reaction, the location of R00927 (Propanoyl-CoA +
Acetyl-CoA = CoA + 2-Methylacetoacetyl-CoA) was
revised from both mitochondria and peroxisomes to only
mitochondria according to its chain length. Subsequently,
in the gap filling step, we found that R01090 (L-Leucine +
2-Oxoglutarate = 4-Methyl-2-oxopentanoate + L-Gluta-
mate) and R04095 (3-Methylbutanoyl-CoA + FAD = 3-
Methylcrotonyl-CoA + FADH2) in this pathway were in
Figure 5 An example pathway of compartmentalized human metabolic network: Valine, leucine and isoleucine degradation pathway.
The reactions in black and not highlighted are in mitochondria. Those highlighted in light blue are in both cytosol and mitochondria. The
reactions with uncertain location (existing exclusively in “uncertain” or in “uncertain” besides mitochondria or cytosol) are highlighted in grey
boxes. The reactions revised in the steps of revision of type c reaction, gap filling, IRLR revision and literature-based revision are in purple, dark
blue, green and red, respectively.
Hao et al. BMC Bioinformatics 2010, 11:393
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two different components in mitochondria, respectively.
These two reactions can actually be connected by R01651
(4-Methyl-2-oxopentanoate + CoA + NAD+ = 3-Methyl-
butanoyl-CoA + CO2 + NADH) whose original location is
“uncertain”. Therefore R01651 was classified as a gap reac-
tion to fill the gap between R01090 and R04095. With this
gap filled, the L-Leucine degradation pathway in mito-
chondria was completed. Similarly, we found that the
three reversible transamination reactions catalyzed by
branched-chain amino-acid aminotransferase (BCAT):
R01090 (L-Leucine + 2-Oxoglutarate = 4-Methyl-2-oxo-
pentanoate + L-Glutamate), R02198 (L-Isoleucine +
2-Oxoglutarate = 3-Methyl-2-oxopentanoate + L-Gluta-
mate) and R01214 (L-Valine + 2-Oxoglutarate =
3-Methyl-2-oxobutanoic acid + L-Glutamate), were iso-
lated reactions in the nucleus. Two BCATs exist in mam-
malian cells: BCATm in mitochondria and BCATc in the
cytosol. BCATm functions in brain and kidney while
BCATc is ubiquitous in most human tissues [25]. There-
fore, this step can occur in both mitochondria and cytosol
but not in the nucleus. Therefore we revised the locations
of these three reactions to cytosol and mitochondria. In
addition, Hutson et al reported that all the steps which
commit the BCAA carbon skeleton to the degradation
pathway take place in mitochondria [26,27]. Based on this
information, eight reactions in the degradation pathway
(R04203, R04204, R05066, R04137, R04224, R03171,
R01210, R01360), which also exist in several other loca-
tions besides mitochondria (such as “uncertain”, cytosol
and peroxisomes), were relocated to be exclusively in
mitochondria. From this example, we can see that the
structure-based and literature-based revisions do greatly
improve the location distribution of the pathways.
4. Transport reactions
It is important to include transport reactions between
different compartments in a localized network in order
to make the network connected. It is unreasonable to
add a transport reaction involving the “uncertain” loca-
tion. Therefore we assigned all the reactions with
“uncertain” location to cytosol as that used in Recon 1
[28]. As Recon 1 already included transport reactions,
we first took it as a reference to add the transport reac-
tions to our network. There are 1190 transport reactions
in Recon 1 and 857 of them are for metabolites that are
also in EHMN. Among the 857 reactions, only 378
reactions that are based on biochemical or genetic
experiments (with confidence score 3 in Recon 1) were
directly added into EHMN. For the 310 reactions based
on physiological data or biochemical/genetic evidence
from a nonhuman mammalian cell (with confidence
score 2 in Recon 1), a transport reaction was added only
if the corresponding metabolite exists in both compart-
ments involved in the transport reaction. The reactions
with confidence score less than 2 in Recon 1 were
ignored because those reactions were added merely
based on in sillico simulation. Finally 546 transport reac-
tions were added from Recon 1 and 429 of them are
related with 212 transport proteins.
At the second step, we searched human transport pro-
teins in TransportDB [29] and all the proteins with gene
ontology annotation GO: 0005215 (transporter activity)
in Uniprot. There are over 1000 transport proteins
obtained from the two resources. However, a large num-
ber of the proteins are ion channel related proteins or
proteins annotated based on sequence similarity but
without clear substrate information. Excluding the 212
transport proteins already obtained from Recon 1, only
a small proportion of the transport proteins were inves-
tigated to add corresponding transport reactions based
on information from the databases and literature. Alto-
gether 109 new transport reactions from 83 transport
proteins were added to EHMN. Some of them are actu-
ally also in Recon 1 but with a low confidence score and
without assigned transport protein.
After adding 655 reactions based on Recon 1 and trans-
porter information from databases and literature, there
are still many gaps between different compartments in
the network mainly because of our limited knowledge on
the function of transport proteins and the existence of
non-protein required transport reactions. To make the
network connected and thus amenable for pathway ana-
lysis, we calculated the “dead ends” in each location for
each pathway (excluding the isolated pathway) and tried
to link the dead ends in different locations by adding new
transport reactions. A dead end was defined as a metabo-
lite that is only produced or consumed in a location. If a
dead end metabolite is also appeared in other locations
then transport reactions are added for it. By default, cyto-
sol was used as a bridge to connect other locations and
transport reaction to/from cytosol were added for the
dead end metabolites. Altogether 961 transport reactions
were identified for the dead end metabolites. Among
them, 193 reactions were already added in the first two
steps (from Recon 1 and transport proteins). Therefore
768 new transport reactions were needed to make the
network connected. It should be noted that the reactions
added solely based on dead end analysis are of low qual-
ity and the existence are subjected to further experimen-
tal investigation. Among these reactions, 73 are between
cytosol and nucleus which actually can be carried out by
the nuclear pore complexes formed by the 49 nucleo-
porin proteins in human [30].
As a summary 1423 transport reactions were added to
the network and 611 of them are associated with trans-
port proteins. The whole network containing 4804 reac-
tions is available at http://www.ehmn.bioinformatics.ed.
ac.uk and free for academic use.
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5. Comparison of EHMN with other human metabolic
networks
Besides EHMN and Recon 1, human metabolic networks
are also available from Reactome [31] and HumanCyc
[32]. HumanCyc is a computationally reconstructed net-
work including 1716 reactions (May 2010 version).
However there is no location information for reactions
included in HumanCyc. Therefore, we mainly compared
the two compartmentalized human metabolic networks
(Recon 1 and Reactome) with EHMN. Reactome con-
tains both metabolic pathways and signal pathways.
Only the 998 reactions in the 12 metabolic pathways
were extracted (see notes of Table 3). Reactions in
Recon 1 were obtained from the BiGG database. The
numbers of reactions in different compartments of the
three networks are shown in Table 3. It can be seen
that comparing with EHMN and Recon 1, the human
metabolic network from Reactome is small. Especially
the reaction information in the compartments other
than cytosol and mitochondria is rather patchy. Due to
the different compound names used in the three net-
works, it is very difficult to check which parts of the
network are common in all three networks. Actually by
matching the compounds through common KEGG com-
pound IDs or exact name we only found 409 common
compounds between EHMN and Reactome and 821
between EHMN and Recon 1. To match reactions
between two networks all the reactants involved in the
reaction need to be matched. Therefore we got even
smaller numbers of matching reactions (229 between
EHMN and Reactome; 578 between EHMN and Recon
1). Many of the common reactions are in the central
pathways, nucleotide metabolism and metabolic path-
ways for some amino acids. However, the small number
of found common reactions makes it very difficult for a
comprehensive comparison of the networks. Generally,
EHMN has more metabolic reactions which are allo-
cated to clear locations (3381 vs 2147) than Recon 1. By
comparing the pathway maps of Recon 1 (supplemen-
tary figures 7, 8, 9, 10, 11, 12, 13, 14 in ref [28]) and
those from EHMN http://www.ehmn.bioinformatics.ed.
ac.uk/pathway/, we can find that many reactions in the
lipids metabolism pathways (ex. linoleate degradation,
omega-3 and omega-6 fatty acid beta-oxidation and
synthesis of some prostaglandins) in EHMN are missing
in Recon 1. There are also some reactions which are in
both networks but are assigned to different locations.
For example, R01975 (3-Hydroxybutanoyl-CoA + NAD+
= Acetoacetyl-CoA + NADH) is a step of Saturated fatty
acids beta-oxidation pathway after octanyl CoA, which
is localized to mitochondria in EHMN but not in per-
oxisomes according to literature [2]. In Recon 1, how-
ever, this reaction occurs in both peroxisomes and
mitochondria. R01324 (Citrate = Isocitrate) was assigned
to cytosol, GA, ER and mitochondria in EHMN whereas
it is only in cytosol and mitochondria in Recon 1. The
extra locations of GA and ER in EHMN are based on
the new evidence that the corresponding enzyme IRP1
is also in the two locations [33].
6. Function analysis of the compartmentalized EHMN
To validate the reconstructed network, we have system-
atically analyzed the pathways for the synthesis and
degradation of certain key metabolites using a newly
developed pathway analysis tool (available on http://
www.ehmn.bioinformatics.ed.ac.uk/path/). Around 70
metabolic conversion processes were examined includ-
ing the synthesis and degradation of amino acids, ribo-
nucleotides, deoxyribonucleotides, fatty acids, sterols,
glycans, prostaglandins and heme (additional file 4: In
Table 3 Sub-cellular location comparison of Human Recon 1, EHMN, and Reactome database
Human Recon 1a Reactomeb EHMN
Metabolic reactions 2147 809(998)c 3381 (4793)d
Extracellular 53 52 234
Nucleus 87 6 226
Cytosol 957 440(629)c 892 (2304)d
Endoplasmic reticulum 187 64 649
Golgi apparatus 253 1 241
Peroxisomes 92 43 291
Lysosomes 190 0 108
Mitochondria 328 203 740
Non-repeat metabolic reactionse 1836 998 2806
Transport reactions 1190 (1596)f 218 1423
a the numbers is based on the data downloaded from BIGG database and may be different from those in their published paper. b the metabolic reactions from
Reactome include metabolism of amino acids and derivatives, carbohydrates, nitric oxide, nucleotides, polyamines, porphyrins, vitamins and cofactors, pyruvate
and citric acid cycle, lipids and lipoproteins, energy, biological oxidations and electron transport chain. The transport reactions include membrane trafficking and
transmembrane transport of small molecules pathways. c the number in the parentheses includes the reactions which were assigned to “cytosol” from unclear
location or locations other than the chosen ones. d the number in the parentheses includes the reaction which are assigned to “cytosol” from “uncertain”. e a
reaction occurs in different locations was counted only once. f the number in the parentheses includes the exchange reactions.
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silico metabolic capability analysis of the compartmenta-
lized EHMN). All the pathways can be visually inspected
through the hyperlinks in the additional file. Actually,
pathways between any two metabolites can be checked
through the pathway analysis tool and this tool has been
used in manual examination of our network. In most
cases, the synthesis/degradation pathways found are in
consistent with those reported in literature or textbooks.
Taking the synthesis of heme as an example (Figure 6),
L-Serine is synthesized in the cytosol and then
transported into mitochondria for the production of
5-Aminolevulinate. Then 5-Aminolevulinate is trans-
ported back into the cytosol for the further synthesis of
Coproporphyrinogen III. The final steps from Copropor-
phyrinogen III to heme take place in mitochondria again
[34,35].
Conclusions
A compartmentalized human metabolic network has
been reconstructed by adding the sub-cellular location
information to enzymes and reactions in EHMN. Net-
work structure analysis and manual curation of litera-
ture were used to improve the quality of the localized
network which was mainly based on protein location
information. Transport reactions were added to obtain a
connected sub-cellular location specific metabolic net-
work. The refined network was validated by in silico
investigation of the metabolic functions for the produc-
tion/degradation of certain important metabolites.
Methods
Localization of human proteins
The protein location information in this work is
extracted mainly from Gene Ontology (GO). Files con-
taining gene-GO association in human and the hierarchi-
cally organized GO terms ("OBO” file) can be easily
downloaded from the GO website. This file is maintained
by the GOA group at EBI which aims to provide high-
quality GO annotations to proteins in the UniProtKB.
GO database provides a controlled vocabulary of hier-
archically organized terms to describe the location in the
“cellular component” category. There are over one thou-
sand GO terms in the “cellular component” category. We
chose eight top locations to compartmentalize the
EHMN based on the cellular structure. The selected loca-
tions and their hierarchical structure are shown in Figure
1. The organelles considered as individual compartments
are nucleus, Endoplasmic Reticulum (ER), Golgi appara-
tus (GA), peroxisomes, lysosomes and mitochondria.
Other organelles such as microsome, cytoskeleton and
small vesicles were not considered because their func-
tions are often not related with cellular metabolism. The
term “plasma membrane” in GO was merged with “cyto-
sol” in this work, so all the proteins which are annotated
in “plasma membrane” in GO were classified to “cytosol”
because they usually catalyze reactions occurring in the
cytosol. From the gene-GO association file, many pro-
teins are actually associated with a subordinate term such
as mitochondrial membrane (GO: 0031966). In these
Protoporphyrinogen IX Coproporphyrinogen III Uroporphyrinogen III
Hydroxymethylbilane
Porphobilinogen5-AminolevulinateGlycine
Protoporphyrin
Succinyl-CoA
Mitochondria Cytosol
Heme
5-Aminolevulinate
Coproporphyrinogen III
L-Serine L-Serine O-Phospho-L-serine
3-Phospho-D-glycerate 3-Phosphonooxypyruvate R01513
R04173
R00582RT0083
R00945
R00830 RT0260 R00036
R00084
R03165
R03197RT0456R03220
R03222
R00310
Figure 6 The Heme synthesis pathway across different locations.
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cases, we traced the GO tree back to a higher-level term
within the eight chosen locations (mitochondria in this
case). The proteins with uncertain locations or other
locations not included in the eight specific locations were
classified to an “uncertain” location. In this way, all the
human proteins coming from GO were classified into the
chosen locations.
To obtain more protein location information and
cross-validate information from different sources, we
also used the Swiss-Prot keywords to extract all the
human proteins related with the keywords. There are
more than eighty locations listed as keywords in the
“cellular component” category in Swiss-Prot keywords,
in which six locations, including nucleus, ER, GA, per-
oxisomes, lysosomes and mitochondria, are same with
the GO terms used in our study. We extracted all the
human proteins related with these location keywords to
get the protein-location relationships.
Gap filling
We developed a method to automatically identify gaps
in the network. For each pathway (excluding isolated
pathway), we extracted a subset of reactions which are
in a specific location and then converted it into a graph.
The group of reactions in a location which can be con-
nected were classified into one component, so the reac-
tions in a location may be divided into several separated
components. It should be noted that only the main
compounds in a reaction were used in linking reactions
and the currency metabolites were ignored [36]. Then
we calculated the connected components in the reaction
graph [37] and obtained a list of main metabolites in
each component. In the next step, we checked every
reaction which is not in this location to see if it contains
main metabolites in two different components. If so, this
reaction will be identified as a gap for that location. This
process was repeated for each location (excluding
“uncertain”) and one reaction may be identified as gaps
in different locations. A gap is a missing reaction-loca-
tion relationship rather than a reaction.
Additional material
Additional file 1: Complementary groups and deleted protein-
reaction relationships in revision of type c reaction. Sheet 1 in this
file contains the 16 complementary groups. Sheet 2 contains the 43
deleted protein-reaction relationships in the revision of type c reaction.
Additional file 2: The reaction location distribution in the pathways
in EHMN. Rows in the matrix stand for the pathways and columns stand
for the locations. A yellow square indicates that there is only one
reaction in a pathway in the corresponding location, while a blue square
means that all the reactions in a pathway are in the corresponding
location. The gray scale reflects the percentage of reactions in a pathway
in the location. Abbreviations: E, Extracellular; N, Nucleus; C, Cytosol; ER,
Endoplasmic reticulum; GA, Golgi apparatus; X, Peroxisomes; L,
Lysosomes; M, Mitochondria.
Additional file 3: Result of literature-based revision. Sheet 1 includes
basic information of location revised reaction (ID, reversibility, equation,
pathway), the reaction location before revision and that after revision.
The reaction in beta-oxidation is marked in column 8 and the
corresponding textbooks and literature are listed in column 9. Sheet 2
contains the deleted protein-reaction relationships. The protein-reaction
relationships deleted in beta-oxidation revision are marked in column 5.
Additional file 4: In silico metabolic capability analysis of the
compartmentalized EHMN. The in silico inspection results of 68
metabolic processes are listed. The hyperlinks for visually checking the
pathways using our web-based pathway analysis tool are included.
Abbreviations
GO: gene ontology; IRLR: isolated reaction-location relationship; E:
Extracellular; U: uncertain; N: Nucleus; C: Cytosol; ER: Endoplasmic reticulum;
GA: Golgi apparatus; X: Peroxisomes; L: Lysosomes; M: Mitochondria; VLCFA:
Very long chain fatty acid.
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